求助文献一篇

Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial，Yan Zhao, MD，Litao Zhang, MD，Jianzhong Zhang, MD 

Published:July 19, 2024DOI:https://doi.org/10.1016/j.jaad.2024.07.1447